[MSB-24] Metabolomic Signatures of Hypothermia Under Cardiopulmonary Bypass: A Systematic Evaluation of Mild and Moderate Hypothermia on Urinary Metabolome Profiles

[MSB-24] 体外循环下低温代谢组学特征:轻度和中度低温对尿液代谢组学特征的系统评价

阅读:1

Abstract

OBJECTIVE: This study aimed to investigate the differential impacts of mild (32 to 35°C) and moderate (26 to 31°C) hypothermia on urinary metabolome profiles during cardiopulmonary bypass (CPB) in adult cardiac surgery. METHODS: This randomized study included 32 patients who underwent CPB under hypothermic conditions (mild, n=16; moderate, n=16) using only the Bretschneider solution. Urine samples were collected at two time points: immediately before CPB initiation and 1 h after rewarming and termination of CPB. Urinary metabolomic analyses were conducted using gas chromatography-mass spectrometry and liquid chromatography-quadrupole timeof-flight mass spectrometry. Metabolite changes were evaluated using statistical methods, including the MannWhitney U test, principal component analysis, and partial least squares discriminant analysis. RESULTS: Significant differences in urinary metabolites were observed between the two hypothermia groups. Mild hypothermia resulted in increased levels of creatinine and 5,6-DHET and decreased levels of 2-methylbutyroylcarnitine and S-adenosylhomocysteine, suggesting a more favorable metabolic response with reduced stress. In contrast, the moderate hypothermia group exhibited increases in metabolites such as C17- sphinganine and ceramide (t18:0/16:0), indicating heightened metabolic stress and potential cellular damage. Principal component analysis and partial least squares discriminant analysis revealed distinct separations between the groups, highlighting greater metabolic perturbations with moderate hypothermia. CONCLUSION: Mild hypothermia is associated with a more stable urinary metabolomic profile, whereas moderate hypothermia is linked to significant metabolic disruptions, necessitating careful monitoring and management. These findings provide valuable insights for optimizing hypothermia protocols during CPB.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。